By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Gelteq Limited Ordinary Shares

Gelteq Limited Ordinary Shares (GELS)

NASDAQ Market Data in USD, Fundamentals in AUD
$409.00
-$3.93
-0.95%
Last Update: 18 Jul 2026, 12:41
$0.00
Market Cap
-1.63k
P/E Ratio (TTM)
Forward Dividend Yield
$295.30-$561.14
52 Week Range

GELS Stock Price Chart

Explore Gelteq Limited Ordinary Shares interactive price chart. Choose custom timeframes to analyze GELS price movements and trends.

GELS Company Profile

Discover essential business fundamentals and corporate details for Gelteq Limited Ordinary Shares (GELS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

29 Oct 2024

Employees

7.00

CEO

Nathan Jacob Givoni

Description

Gelteq Limited, established in 2017 and based in Caulfield, Australia, specializes in creating and commercializing advanced gel-based delivery methods for both human and animal use. The company offers customizable, white-label gel formulations that can be applied to a broad array of goods, such as prescribed pharmaceuticals, non-prescription remedies, nutritional supplements (including sports-related products), and veterinary care items.

GELS Financial Timeline

Browse a chronological timeline of Gelteq Limited Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

GELS Stock Performance

Access detailed GELS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run